Mental health is correlated with lipoprotein(a) levels in male patients with premature coronary heart disease

被引:6
作者
Bao, Jinlan [1 ,2 ]
Zheng, Shaoxin [1 ,2 ]
Huang, Jingjing [1 ,2 ]
Xie, Xiangkun [1 ,2 ]
Zhang, Jinglu [3 ]
Yang, Shiliang [3 ]
Wu, Xiaoying [1 ,2 ]
Zhang, Yuling [1 ,2 ]
机构
[1] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Cardiol, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangzhou Key Lab Mol Mech & Translat Major Cardi, Guangzhou, Peoples R China
[3] Sun Yat Sen Univ, Dept Gen Practice, Sun Yat Sen Mem Hosp, Guangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
Mental health; lipoprotein(a) levels (Lp(a) levels); premature coronary heart disease (PCHD); QUALITY-OF-LIFE; PSYCHOSOCIAL RISK-FACTORS; CARDIOVASCULAR RISK; MYOCARDIAL-INFARCTION; PHYSICAL-ACTIVITY; ASSOCIATION; CHOLESTEROL; PREVENTION; PROGNOSIS; EVENTS;
D O I
10.21037/apm-21-1024
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: High levels of lipoprotein(a) (Lp(a)) is an independent risk factor for premature coronary heart disease (PCHD). It is also considered a residual risk for controlled low density lipoprotein cholesterol (LDL-C). Dietary control, exercise, and drugs have limited effects on the levels of Lp(a). Recently, mental health was found to be associated with lipid levels and increased risk of PCHD. However, the relationship between mental health and Lp(a) is still unknown. This study explored the association between mental health and Lp(a) levels in men with PCHD. Methods: A retrospective, observational study was conducted. A total of 226 male patients with PCHD, aged 49.65 +/- 3.68 years, was included in this study. The control group consisted of 230 age-matched healthy male volunteers. Serum Lp(a) levels =30 mg/dL, as measured by the immunoturbidimetry method, were considered high. All participants received health related quality of life (HRQoL) scores using the selfassessed 36-Item Short Form Health Survey (SF-36). The HRQoL includes both a physical component summary (PCS) and a mental component summary (MCS). Results: Patients with PCHD were found to have higher levels of Lp(a) (51.61 +/- 33.39 vs. 26.42 +/- 21.93, P<0.001), and lower MCS (35.83 +/- 4.21 vs. 39.85 +/- 4.12) and PCS scores (38.02 +/- 3.73 vs. 39.63 +/- 3.21) compared to healthy volunteers. The MCS score was negatively correlated with Lp(a) levels in the PCHD group (R=-0.295, P<0.001), but no correlation was detected in the control group. There was no relationship between the PCS score and Lp( a) levels in neither the PCHD group nor the healthy control group. Multivariate logistic regression analysis indicated that the MCS and PCS scores were negatively correlated with the risk of PCHD. Conclusions: These findings suggested that poor mental health may be associated with high levels of Lp(a) and increased risk of PCHD in men. Therefore, improving the mental state in men with PCHD may be crucial.
引用
收藏
页码:6482 / +
页数:12
相关论文
共 56 条
  • [1] Premature coronary heart disease and autosomal dominant hypercholesterolemia: Increased risk in women with LDLR mutations
    Ahmad, Zahid
    Li, Xilong
    Wosik, Jedrek
    Mani, Preethi
    Petr, Joye
    McLeod, George
    Murad, Shatha
    Song, Li
    Adams-Huet, Beverley
    Garg, Abhimanyu
    [J]. JOURNAL OF CLINICAL LIPIDOLOGY, 2016, 10 (01) : 101 - 108
  • [2] 2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult
    Anderson, Todd J.
    Gregoire, Jean
    Pearson, Glen J.
    Barry, Arden R.
    Couture, Patrick
    Dawes, Martin
    Francis, Gordon A.
    Genest, Jacques
    Grover, Steven
    Gupta, Milan
    Hegele, Robert A.
    Lau, David C.
    Leiter, Lawrence A.
    Lonn, Eva
    Mancini, G. B. John
    McPherson, Ruth
    Ngui, Daniel
    Poirier, Paul
    Sievenpiper, John L.
    Stone, James A.
    Thanassoulis, George
    Ward, Richard
    [J]. CANADIAN JOURNAL OF CARDIOLOGY, 2016, 32 (11) : 1263 - 1282
  • [3] Effect of Ezetimibe Monotherapy on Plasma Lipoprotein(a) Concentrations in Patients with Primary Hypercholesterolemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Awad, Kamal
    Mikhailidis, Dimitri P.
    Katsiki, Niki
    Muntner, Paul
    Banach, Maciej
    [J]. DRUGS, 2018, 78 (04) : 453 - 462
  • [4] Health-related quality of life and risk of composite coronary heart disease and cerebrovascular events in the Moli-sani study cohort
    Bonaccio, Marialaura
    Di Castelnuovo, Augusto
    Costanzo, Simona
    Persichillo, Mariarosaria
    De Curtis, Amalia
    Cerletti, Chiara
    Donati, Maria Benedetta
    de Gaetano, Giovanni
    Iacoviello, Licia
    [J]. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2018, 25 (03) : 287 - 297
  • [5] Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies A Mendelian Randomization Analysis
    Burgess, Stephen
    Ference, Brian A.
    Staley, James R.
    Freitag, Daniel F.
    Mason, Amy M.
    Nielsen, Sune F.
    Willeit, Peter
    Young, Robin
    Surendran, Praveen
    Karthikeyan, Savita
    Bolton, Thomas R.
    Peters, James E.
    Kamstrup, Pia R.
    Tybjaerg-Hansen, Anne
    Benn, Marianne
    Langsted, Anne
    Schnohr, Peter
    Vedel-Krogh, Signe
    Kobylecki, Camilla J.
    Ford, Ian
    Packard, Chris
    Trompet, Stella
    Jukema, J. Wouter
    Sattar, Naveed
    Di Angelantonio, Emanuele
    Saleheen, Danish
    Howson, Joanna M. M.
    Nordestgaard, Borge G.
    Butterworth, Adam S.
    Danesh, John
    [J]. JAMA CARDIOLOGY, 2018, 3 (07) : 619 - 627
  • [6] Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
    Cannon, Christopher P.
    Blazing, Michael A.
    Giugliano, Robert P.
    McCagg, Amy
    White, Jennifer A.
    Theroux, Pierre
    Darius, Harald
    Lewis, Basil S.
    Ophuis, Ton Oude
    Jukema, J. Wouter
    De Ferrari, Gaetano M.
    Ruzyllo, Witold
    De Lucca, Paul
    Im, KyungAh
    Bohula, Erin A.
    Reist, Craig
    Wiviott, Stephen D.
    Tershakovec, Andrew M.
    Musliner, Thomas A.
    Braunwald, Eugene
    Califf, Robert M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (25) : 2387 - 2397
  • [7] Measuring health related quality of life in coronary heart disease: The importance of feeling well
    Cepeda-Valery, Beatriz
    Cheong, Adrian P.
    Lee, Andrea
    Yan, Bryan P.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 149 (01) : 4 - 9
  • [8] Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease
    Clarke, Robert
    Peden, John F.
    Hopewell, Jemma C.
    Kyriakou, Theodosios
    Goel, Anuj
    Heath, Simon C.
    Parish, Sarah
    Barlera, Simona
    Franzosi, Maria Grazia
    Rust, Stephan
    Bennett, Derrick
    Silveira, Angela
    Malarstig, Anders
    Green, Fiona R.
    Lathrop, Mark
    Gigante, Bruna
    Leander, Karin
    de Faire, Ulf
    Seedorf, Udo
    Hamsten, Anders
    Collins, Rory
    Watkins, Hugh
    Farrall, Martin
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (26) : 2518 - 2528
  • [9] LIPOPROTEIN LP(A) AS PREDICTOR OF MYOCARDIAL-INFARCTION IN COMPARISON TO FIBRINOGEN - LDL CHOLESTEROL AND OTHER RISK-FACTORS - RESULTS FROM THE PROSPECTIVE GOTTINGEN RISK INCIDENCE AND PREVALENCE STUDY (GRIPS)
    CREMER, P
    NAGEL, D
    LABROT, B
    MANN, H
    MUCHE, R
    ELSTER, H
    SEIDEL, D
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1994, 24 (07) : 444 - 453
  • [10] Health related quality of life in coronary patients and its association with their cardiovascular risk profile: Results from the EUROASPIRE III survey
    De Smedt, Delphine
    Clays, Els
    Annemans, Lieven
    Doyle, Frank
    Kotseva, Kornelia
    Pajak, Andrzej
    Prugger, Christof
    Jennings, Catriona
    Wood, David
    De Bacquer, Dirk
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (02) : 898 - 903